{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:28:41Z","timestamp":1793921321454,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012207"],"award-info":[{"award-number":["2024A1515012207"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515030040"],"award-info":[{"award-number":["2023A1515030040"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Plan Projects of Gansu Province","award":["25JRRA1295"],"award-info":[{"award-number":["25JRRA1295"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303738"],"award-info":[{"award-number":["82303738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02742-2","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:42:57Z","timestamp":1784508177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Yidan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"1","key":"2742_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2742_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19(2):91\u2013113.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10286","key":"2742_CR3","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397(10286):1750\u201369.","journal-title":"Lancet"},{"issue":"10","key":"2742_CR4","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cac2.12358","volume":"42","author":"R Hong","year":"2022","unstructured":"Hong R, Xu B. Breast cancer: an up-to-date review and future perspectives. Cancer Commun (Lond). 2022;42(10):913\u201336.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"2742_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"11","key":"2742_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.tem.2025.03.008","volume":"36","author":"J Cheng","year":"2025","unstructured":"Cheng J, Xiao Y, Jiang P. Fumarate integrates metabolism and immunity in diseases. Trends Endocrinol Metab. 2025;36(11):985\u201399.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2742_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molmed.2016.12.001","volume":"23","author":"GM Fuhler","year":"2017","unstructured":"Fuhler GM, Eppinga H, Peppelenbosch MP. Fumarates and Cancer. Trends Mol Med. 2017;23(1):3\u20135.","journal-title":"Trends Mol Med"},{"key":"2742_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcdb.2019.05.002","volume":"98","author":"C Schmidt","year":"2020","unstructured":"Schmidt C, Sciacovelli M, Frezza C. Fumarate hydratase in cancer: A multifaceted tumour suppressor. Semin Cell Dev Biol. 2020;98:15\u201325.","journal-title":"Semin Cell Dev Biol"},{"issue":"8049","key":"2742_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-024-08335-7","volume":"638","author":"G Doglioni","year":"2025","unstructured":"Doglioni G, Fern\u00e1ndez-Garc\u00eda J, Igelmann S, Altea-Manzano P, Blomme A, La Rovere R, et al. Aspartate signalling drives lung metastasis via alternative translation. Nature. 2025;638(8049):244\u201350.","journal-title":"Nature"},{"issue":"1","key":"2742_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.celrep.2015.08.072","volume":"13","author":"JR Gooding","year":"2015","unstructured":"Gooding JR, Jensen MV, Dai X, Wenner BR, Lu D, Arumugam R, et al. Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism. Cell Rep. 2015;13(1):157\u201367.","journal-title":"Cell Rep"},{"issue":"4","key":"2742_CR11","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41374-017-0017-0","volume":"98","author":"H Park","year":"2018","unstructured":"Park H, Ohshima K, Nojima S, Tahara S, Kurashige M, Hori Y, et al. Adenylosuccinate lyase enhances aggressiveness of endometrial cancer by increasing killer cell lectin-like receptor C3 expression by fumarate. Lab Invest. 2018;98(4):449\u201361.","journal-title":"Lab Invest"},{"issue":"9","key":"2742_CR12","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.7150\/thno.50051","volume":"11","author":"S Taha-Mehlitz","year":"2021","unstructured":"Taha-Mehlitz S, Bianco G, Coto-Llerena M, Kancherla V, Bantug GR, Gallon J, et al. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis. Theranostics. 2021;11(9):4011\u201329.","journal-title":"Theranostics"},{"issue":"6","key":"2742_CR13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41589-024-01825-9","volume":"21","author":"L Wang","year":"2025","unstructured":"Wang L, Shi R, Wang S, Duan Y, Wang Z, Zheng P, et al. ADSL promotes autophagy and tumor growth through fumarate-mediated Beclin1 dimethylation. Nat Chem Biol. 2025;21(6):894\u2013905.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"2742_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41556-025-01627-8","volume":"27","author":"Y Duan","year":"2025","unstructured":"Duan Y, Hu Z, Han P, Lei B, Wang S, Wang Z, et al. ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion. Nat Cell Biol. 2025;27(4):668\u201382.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2742_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-023-01439-y","volume":"8","author":"X Wu","year":"2023","unstructured":"Wu X, Xu M, Geng M, Chen S, Little PJ, Xu S, et al. Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. Signal Transduct Target Ther. 2023;8(1):220.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2742_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2006.03.005","volume":"450","author":"NL Alderson","year":"2006","unstructured":"Alderson NL, Wang Y, Blatnik M, Frizzell N, Walla MD, Lyons TJ, et al. S-(2-Succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate. Arch Biochem Biophys. 2006;450(1):1\u20138.","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"2742_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","volume":"20","author":"J Adam","year":"2011","unstructured":"Adam J, Hatipoglu E, O\u2019Flaherty L, Ternette N, Sahgal N, Lockstone H, et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell. 2011;20(4):524\u201337.","journal-title":"Cancer Cell"},{"key":"2742_CR18","doi-asserted-by":"crossref","unstructured":"Ge X, Li M, Yin J, Shi Z, Fu Y, Zhao N et al. Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma. Mol Cell. 2022;82(7):1249-60.e7.","DOI":"10.1016\/j.molcel.2022.01.029"},{"issue":"6","key":"2742_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cmet.2023.04.017","volume":"35","author":"J Cheng","year":"2023","unstructured":"Cheng J, Yan J, Liu Y, Shi J, Wang H, Zhou H, et al. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8(+) T cells in the tumor microenvironment. Cell Metab. 2023;35(6):961\u2013e7810.","journal-title":"Cell Metab"},{"issue":"8","key":"2742_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41580-022-00465-y","volume":"23","author":"CE Buckley","year":"2022","unstructured":"Buckley CE, St Johnston D. Apical-basal polarity and the control of epithelial form and function. Nat Rev Mol Cell Biol. 2022;23(8):559\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2742_CR21","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1158\/0008-5472.CAN-13-3415","volume":"74","author":"ME Feigin","year":"2014","unstructured":"Feigin ME, Akshinthala SD, Araki K, Rosenberg AZ, Muthuswamy LB, Martin B, et al. Mislocalization of the cell polarity protein scribble promotes mammary tumorigenesis and is associated with basal breast cancer. Cancer Res. 2014;74(11):3180\u201394.","journal-title":"Cancer Res"},{"issue":"5","key":"2742_CR22","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/hep.29669","volume":"67","author":"S Wan","year":"2018","unstructured":"Wan S, Meyer AS, Weiler SME, Rupp C, T\u00f3th M, Sticht C, et al. Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness. Hepatology. 2018;67(5):1842\u201356.","journal-title":"Hepatology"},{"issue":"6","key":"2742_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s43018-023-00575-2","volume":"4","author":"Y Adachi","year":"2023","unstructured":"Adachi Y, Kimura R, Hirade K, Yanase S, Nishioka Y, Kasuga N, et al. Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRAS. Nat Cancer. 2023;4(6):829\u201343.","journal-title":"Nat Cancer"},{"key":"2742_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2017.02.037","volume":"175","author":"N Dey","year":"2017","unstructured":"Dey N, De P, Leyland-Jones B. PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials. Pharmacol Ther. 2017;175:91\u2013106.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2742_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-018-0794-0","volume":"17","author":"A Jebali","year":"2018","unstructured":"Jebali A, Dumaz N. The role of RICTOR downstream of receptor tyrosine kinase in cancers. Mol Cancer. 2018;17(1):39.","journal-title":"Mol Cancer"},{"issue":"739","key":"2742_CR26","doi-asserted-by":"publisher","first-page":"eadg5553","DOI":"10.1126\/scitranslmed.adg5553","volume":"16","author":"J Yin","year":"2024","unstructured":"Yin J, Ge X, Ding F, He L, Song K, Shi Z, et al. Reactivating PTEN to impair glioma stem cells by inhibiting cytosolic iron-sulfur assembly. Sci Transl Med. 2024;16(739):eadg5553.","journal-title":"Sci Transl Med"},{"issue":"7952","key":"2742_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41586-023-05720-6","volume":"615","author":"A Hooftman","year":"2023","unstructured":"Hooftman A, Peace CG, Ryan DG, Day EA, Yang M, McGettrick AF, et al. Macrophage fumarate hydratase restrains mtRNA-mediated interferon production. Nature. 2023;615(7952):490\u20138.","journal-title":"Nature"},{"issue":"11","key":"2742_CR28","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.cmet.2023.10.002","volume":"35","author":"J Li","year":"2023","unstructured":"Li J, Zheng C, Mai Q, Huang X, Pan W, Lu J, et al. Tyrosine catabolism enhances genotoxic chemotherapy by suppressing translesion DNA synthesis in epithelial ovarian cancer. Cell Metab. 2023;35(11):2044\u2013e598.","journal-title":"Cell Metab"},{"issue":"1","key":"2742_CR29","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1038\/s41467-019-13168-4","volume":"10","author":"G Zurlo","year":"2019","unstructured":"Zurlo G, Liu X, Takada M, Fan C, Simon JM, Ptacek TS, et al. Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer. Nat Commun. 2019;10(1):5177.","journal-title":"Nat Commun"},{"issue":"4","key":"2742_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41589-018-0217-y","volume":"15","author":"RA Kulkarni","year":"2019","unstructured":"Kulkarni RA, Bak DW, Wei D, Bergholtz SE, Briney CA, Shrimp JH, et al. A chemoproteomic portrait of the oncometabolite fumarate. Nat Chem Biol. 2019;15(4):391\u2013400.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"2742_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1021\/acschembio.4c00617","volume":"20","author":"L Zhang","year":"2025","unstructured":"Zhang L, Martin JG, Gao B, Zeng W, Couvertier S, Johnson DS. Chemoproteomic Profiling of Clickable Fumarate Probes for Target Identification and Mechanism of Action Studies. ACS Chem Biol. 2025;20(2):340\u201356.","journal-title":"ACS Chem Biol"},{"issue":"7631","key":"2742_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nature20144","volume":"540","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli M, Gon\u00e7alves E, Johnson TI, Zecchini VR, da Costa AS, Gaude E, et al. Corrigendum: Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature. 2016;540(7631):150.","journal-title":"Nature"},{"issue":"19","key":"2742_CR33","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.jmb.2017.08.007","volume":"429","author":"H Tarhonskaya","year":"2017","unstructured":"Tarhonskaya H, Nowak RP, Johansson C, Szykowska A, Tumber A, Hancock RL, et al. Studies on the Interaction of the Histone Demethylase KDM5B with Tricarboxylic Acid Cycle Intermediates. J Mol Biol. 2017;429(19):2895\u2013906.","journal-title":"J Mol Biol"},{"issue":"7813","key":"2742_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-020-2363-0","volume":"582","author":"PL Sulkowski","year":"2020","unstructured":"Sulkowski PL, Oeck S, Dow J, Economos NG, Mirfakhraie L, Liu Y, et al. Oncometabolites suppress DNA repair by disrupting local chromatin signalling. Nature. 2020;582(7813):586\u201391.","journal-title":"Nature"},{"issue":"47","key":"2742_CR35","doi-asserted-by":"publisher","first-page":"7019","DOI":"10.1038\/s41388-020-01478-7","volume":"39","author":"MJ Santoni","year":"2020","unstructured":"Santoni MJ, Kashyap R, Camoin L, Borg JP. The Scribble family in cancer: twentieth anniversary. Oncogene. 2020;39(47):7019\u201333.","journal-title":"Oncogene"},{"issue":"9","key":"2742_CR36","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nchembio.2119","volume":"12","author":"B Chen","year":"2016","unstructured":"Chen B, Zheng B, DeRan M, Jarugumilli GK, Fu J, Brooks YS, et al. ZDHHC7-mediated S-palmitoylation of Scribble regulates cell polarity. Nat Chem Biol. 2016;12(9):686\u201393.","journal-title":"Nat Chem Biol"},{"key":"2742_CR37","first-page":"0313","volume":"7","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Hu X, Yu H, Sun H, Zhang L, Shao C. The FTO Mediated N6-Methyladenosine Modification of DDIT4 Regulation with Tumorigenesis and Metastasis in Prostate Cancer. Res (Wash D C). 2024;7:0313.","journal-title":"Res (Wash D C)"},{"issue":"2","key":"2742_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.molcel.2013.05.003","volume":"51","author":"LB Sullivan","year":"2013","unstructured":"Sullivan LB, Martinez-Garcia E, Nguyen H, Mullen AR, Dufour E, Sudarshan S, et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol Cell. 2013;51(2):236\u201348.","journal-title":"Mol Cell"},{"issue":"2","key":"2742_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov. 2019;9(2):176\u201398.","journal-title":"Cancer Discov"},{"issue":"5","key":"2742_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","volume":"32","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Ma D, Yang YS, Yang F, Ding JH, Gong Y, et al. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell Res. 2022;32(5):477\u201390.","journal-title":"Cell Res"},{"issue":"4","key":"2742_CR41","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147(4):759\u201372.","journal-title":"Cell"},{"issue":"4","key":"2742_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu GY, Sabatini DM. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. 2020;21(4):183\u2013203.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02742-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02742-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02742-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:22:32Z","timestamp":1792160552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02742-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2742"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02742-2","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"242"}}